Skip to main content
Premium Trial:

Request an Annual Quote

Tripos to Sell Informatics Business to Vector Capital for $25.6M as First Step in Liquidation

NEW YORK (GenomeWeb News) - Tripos today said it has agreed to sell its Discovery Informatics business to San Francisco-based Vector Capital for $26.5 million in cash as an “initial step” in the liquidation of the company.
The transaction is expected to close in the first quarter of 2007.
Vector Capital is a boutique private equity firm that specializes in technology recapitalization deals, buyouts, and spin-outs.
Tripos disclosed its plans to sell its Discovery Informatics and Discovery Research businesses last week.
Tripos said that it expects to distribute between $6 million to $12 million to its shareholders assuming completion of the sale of its Discovery Informatics business to Vector, sale of its Discovery Research business, and completion of certain other transactions.
The sale of the Discovery Informatics assets to Vector will allow the business “to continue to serve its computational chemistry and enterprise research IT customers as a private company with greater access to growth capital," said John McAlister, president and CEO of Tripos, in a statement.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.